RadNet, Inc.
Financials
Valuation Metrics
RadNet, Inc.'s Market Cap is $5.25B. At end of 2025 it was $5.36B. Ranked #1378 of 3,111 in US market (top 44%), #473 of 1,445 on NASDAQ (top 33%), #84 of 206 in Health Care Equipment & Services (top 41%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $5.25B | US#1,378/3,111 Sec#84/206 |
| Revenue | $2.14B | US#1,439/3,111 Sec#91/206 |
| Net Income | $-14M | US—/3,111 Sec—/206 |
| Total Assets | $3.89B | US#1,622/3,111 Sec#75/206 |
| Net Assets | $1.08B | US#1,727/3,111 Sec#90/206 |
| Employees | 8,844 | US#642/3,111 Sec#59/206 |
| Value | ||
| P/B | 4.86x | US#2,130/3,111 Sec#134/206 |
| P/S | 2.45x | US#1,449/3,111 Sec#107/206 |
| EV/EBITDA | 20.78x | US#1,869/3,111 Sec#86/206 |
| FCF Yield | -2.83% | US—/3,111 Sec—/206 |
| Profitability | ||
| ROE | -1.31% | US#2,207/3,111 Sec#113/206 |
| ROA | -0.37% | US#2,254/3,111 Sec#117/206 |
| Op. Margin | 3.84% | US#2,178/3,111 Sec#108/206 |
| Revenue Growth | 22.11% | US#684/3,111 Sec#42/206 |
| Earnings Growth | -767.81% | US#2,356/3,111 Sec#124/206 |
| Financial Health | ||
| Debt Ratio | 234.39% | US#1,937/3,111 Sec#166/206 |
| Total Debt | $1.93B | US#1,177/3,111 Sec#60/206 |
| FCF | $-149M | US#2,691/3,111 Sec#198/206 |
| Cash | $455M | US#1,130/3,111 Sec#68/206 |
| Current Ratio | 1.17x | US#2,051/3,111 Sec#181/206 |
| Net Debt/EBITDA | 4.56x | US#1,965/3,111 Sec#124/206 |
| Performance | ||
| 1Y Return | 22.14% | US#1,527/3,111 Sec#103/206 |
| 1M Return | -2.84% | US#1,877/3,111 Sec#125/206 |
| From 52W High | -22.18% | US#1,927/3,111 Sec#130/206 |
| 1Y MDD | -38.60% | US#1,886/3,111 Sec#98/206 |
| Trading | ||
| Volume | 779,617 shares | US#1,908/3,111 Sec#122/206 |
| Trading Value | $52M | US#1,543/3,111 Sec#105/206 |
| Per Share | ||
| EPS | $-0.25 | US—/3,111 Sec—/206 |
| BPS | $14.50 | US#1,507/3,111 Sec#86/206 |
Company Info
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.